摘要
目的观察丹参注射液联合依达拉奉治疗急性脑梗死的临床效果。方法选择医院2015年6月-2016年6月收治的急性脑梗死患者88例,将其按照奇偶数字法随机分为观察组和对照组各44例。对照组给予依达拉奉治疗,观察组在对照组治疗的基础上给予丹参注射液治疗,比较2组治疗效果。结果治疗前2组日常生活能力量表(ADL)评分和美国卫生研究院的卒中量表(NIHSS)评分比较差异均无统计学意义(P>0.05),治疗后2组ADL评分均升高,NIHSS评分均下降,且观察组优于对照组,差异均有统计学意义(P<0.05)。观察组总有效率为97.73%高于对照组的81.82%,差异有统计学意义(P<0.05)。结论丹参注射液联合依达拉奉治疗急性脑梗死效果好,且安全性高,值得临床推广及应用。
Objective To observe the clinical effect of salvia miltiorrhiza injection combined with edaravone in the treatment of acute cerebral infarction. Methods 88 cases of patients with acute cerebral infarction were selected,which were treated in hospital from June 2015 to June 2016,and they were randomly divided into observation group and control group according to the odd and even digital method. The control group was treated with edaravone,on the basis of the control group,the observation group was treated with Danshen injection,and the treatment effect of two groups was compared. Results There was no significant difference between ADL score and NIHSS score before treatment（ P 〉 0. 05）,the scores of ADL were increased in both groups after treatment,NIHSS scores were decreased,and the observation group was superior to the control group,the difference was statistically significant（ P 〈 0. 05）. The total effective rate of the observation group（ 97. 73%） was higher than that of the control group（ 81. 82%）,the difference was statistically significant（ P 〈 0. 05）. Conclusion Acute cerebral infarction were treated by salvia miltiorrhiza injection and with edaravone in combination treatment,not only the treatment effect is good,and high safety,worthy of clinical popularization and application.
出处
《临床合理用药杂志》
2017年第31期9-10,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
急性脑梗死
丹参注射液
依达拉奉
Acute cerebral infarction
Salvia miltiorrhiza injection
According to the adr
